ARIBIO CO LTD

ARIBIO CO LTD is a developer and manufacturer of biopharmaceutical products, not a trading company.

Company Introduction:

ARIBIO CO LTD is a clinical-stage biopharmaceutical company headquartered in South Korea. The company is focused on the discovery and development of innovative drug candidates, particularly for neurodegenerative diseases such as Alzheimer's disease. ARIBIO conducts extensive research and development (R&D) efforts, progressing through preclinical studies and multiple phases of clinical trials. Their mission is to develop and commercialize novel therapeutics that address significant unmet medical needs. As a pharmaceutical company, they are involved in the creation, development, and eventual production of their own intellectual property and drug products, rather than simply distributing or trading existing goods.

Here are the products that ARIBIO CO LTD of South Korea manufactures or sells:

* AR1001 (Alzheimer's Disease treatment)

* Oral Donepezil Fast Disintegrating Tablet

* COVID-19 related products (likely diagnostic kits or related reagents)

* Cosmetics (Mask pack, skincare products)

* Dietary Supplements/Health Functional Foods